Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 3, Issue 2, Pages 109-121
http://dx.doi.org/10.4161/oxim.3.2.11354

Calcific Uremic Arteriolopathy: Pathophysiology, Reactive Oxygen Species and Therapeutic Approaches

1University of Maryland, Division of Nephrology, Columbia, MI, USA
2University of Maryland, Division of Physiology, Columbia, MI, USA
3University of Missouri School of Medicine, Department of Internal Medicine, Columbia, MI, USA
4University of Missouri School of Medicine, Department of Endocrinology Diabetes and Metabolism, Columbia, MI, USA
5Diabetes and Cardiovascular Disease Research Center, University of Missouri School of Medicine, Columbia, MI, USA

Received 21 January 2010; Revised 29 January 2010; Accepted 1 February 2010

Copyright © 2010 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Kurt M. Sowers and Melvin R. Hayden, “Calcific Uremic Arteriolopathy: Pathophysiology, Reactive Oxygen Species and Therapeutic Approaches,” Oxidative Medicine and Cellular Longevity, vol. 3, no. 2, pp. 109-121, 2010. https://doi.org/10.4161/oxim.3.2.11354.